A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Active Commerce on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Worries
However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.
Some professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the service has removed violative material and banned related keywords and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with numerous of users, filled with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.
After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Within these groups, posts show black plastic parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously seen individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may subject users to possibly significant health risks”.
